Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001475026 | SCV001679207 | likely benign | Menkes kinky-hair syndrome; Cutis laxa, X-linked; X-linked distal spinal muscular atrophy type 3 | 2024-08-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002329571 | SCV002632214 | uncertain significance | Inborn genetic diseases | 2022-03-20 | criteria provided, single submitter | clinical testing | The p.G1451D variant (also known as c.4352G>A), located in coding exon 22 of the ATP7A gene, results from a G to A substitution at nucleotide position 4352. The glycine at codon 1451 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
ARUP Laboratories, |
RCV005232345 | SCV005877173 | uncertain significance | not provided | 2024-10-03 | criteria provided, single submitter | clinical testing | The ATP7A c.4352G>A; p.Gly1451Asp variant (rs782232632), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 1138621). This variant is found in the non-Finnish European population with an allele frequency of 0.004% (4/92,707 alleles, including 2 hemizygotes) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.292). Due to limited information, the clinical significance of this variant is uncertain at this time. |